Astrana Health Files 8-K on Financials

Ticker: ASTH · Form: 8-K · Filed: Nov 7, 2024 · CIK: 1083446

Astrana Health, INC. 8-K Filing Summary
FieldDetail
CompanyAstrana Health, INC. (ASTH)
Form Type8-K
Filed DateNov 7, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-K, company-update

TL;DR

Astrana Health dropped an 8-K with financial updates. Check it out.

AI Summary

Astrana Health, Inc. filed an 8-K on November 7, 2024, reporting on its results of operations and financial condition, and including financial statements and exhibits. The company, formerly known as Apollo Medical Holdings, Inc., is incorporated in Delaware and headquartered in Alhambra, California.

Why It Matters

This filing provides investors with updated financial information and operational details for Astrana Health, Inc., crucial for assessing the company's performance and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial filing (8-K) that doesn't indicate any immediate or significant negative events.

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K?

The 8-K indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of these financials are not provided in the header information.

When was Astrana Health, Inc. previously known by another name?

Astrana Health, Inc. was formerly known as Apollo Medical Holdings, Inc., with a name change date of July 15, 2008.

What is Astrana Health, Inc.'s primary business classification?

The company's Standard Industrial Classification (SIC) code is 8742, which corresponds to SERVICES-MANAGEMENT CONSULTING SERVICES.

Where are Astrana Health, Inc.'s principal executive offices located?

The principal executive offices are located at 1668 S. Garfield Avenue, 2nd Floor, Alhambra, California 91801.

What is the SEC file number for Astrana Health, Inc.?

The SEC file number for Astrana Health, Inc. is 001-37392.

Filing Stats: 568 words · 2 min read · ~2 pages · Grade level 9.5 · Accepted 2024-11-07 17:14:00

Key Financial Figures

Filing Documents

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On November 7, 2024, Astrana Health, Inc. (the "Company") issued a press release announcing its financial results for the three and nine months ended September 30, 2024. A copy of the press release and supplemental data is furnished with this Current Report on Form 8-K as Exhibit 99.1 and Exhibit 99.2 , respectively, and incorporated herein by reference. In accordance with General Instruction B.2 of Form 8-K, the information furnished pursuant to this Item 2.02, including Exhibit 99.1 and Exhibit 99.2 furnished herewith, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Astrana Health, Inc. Regarding its Financial Results for the Three and Nine Months Ended September 30, 2024, dated November 7, 2024. 99.2 Supplemental Data of Astrana Health, Inc., dated November 7, 2024. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASTRANA HEALTH, INC. Date: November 7, 2024 By: /s/ Brandon K. Sim Name: Brandon K. Sim Title: Chief Executive Officer and President

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing